Moderna (MRNA) Misses Q3 EPS by 228c

Moderna (NASDAQ: MRNA) reported Q3 EPS of $2.53, $2.28 worse than the analyst estimate of $4.81. Revenue for the quarter came in at $3.36 billion versus the consensus estimate of $4.63 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery